Get started
AMGEN 11/41AMGEN 11/41AMGEN 11/41

AMGEN 11/41

No trades
See on Supercharts
Overview
Analysis News

US31162BK5 chart


Full chart

Key terms


Outstanding amount
‪728.89 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
5.15% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.07%
Maturity date
Nov 15, 2041
Term to maturity
17 years

About AMGEN 11/41


Issuer
Amgen, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
amgen.com
Issue date
Nov 10, 2011
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

News